​

Inspire Medical Systems (INSP) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

INSP Stock Forecast

Inspire Medical Systems (INSP) stock forecast, based on 27 Wall Street analysts, predicts a 12-month average price target of $91.33, with a high of $180.00 and a low of $56.00. This represents a 61.19% increase from the last price of $56.66.

$50 $90 $130 $170 $210 $250 High: $180 Avg: $91.33 Low: $56 Last Closed Price: $56.66

INSP Stock Rating

Inspire Medical Systems stock's rating consensus is Hold, based on 27 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 13 Buy (48.15%), 14 Hold (51.85%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Hold
Total 27 0 14 13 Strong Sell Sell Hold Buy Strong Buy

INSP Price Target Upside V Benchmarks

TypeNameUpside
StockInspire Medical Systems61.19%
SectorHealthcare Stocks 15.45%
IndustryMedical Device Stocks33.37%

Price Target Trends

1M3M12M
# Anlaysts41745
Avg Price Target$65.00$79.76$117.42
Last Closing Price$56.66$56.66$56.66
Upside/Downside14.72%40.77%107.24%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Apr, 261410--15
Mar, 261412--17
Feb, 26169--16
Jan, 26296--17
Dec, 25377--17
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Apr 15, 2026Truist Financial$64.00$57.5911.13%12.95%
Apr 14, 2026Shagun SinghRBC Capital$56.00$54.921.97%-1.16%
Apr 13, 2026Mizuho Securities$70.00$53.4231.04%23.54%
Apr 10, 2026Stifel Nicolaus$70.00$53.9629.73%23.54%
Mar 05, 2026Jonathan BlockStifel Nicolaus$85.00$62.2936.46%50.02%
Feb 18, 2026Morgan Stanley$60.00$61.95-3.15%5.89%
Feb 13, 2026UBS$67.00$63.066.25%18.25%
Feb 12, 2026RBC Capital$68.00$62.049.61%20.01%
Feb 12, 2026Piper Sandler$85.00$68.2124.62%50.02%
Feb 12, 2026Mizuho Securities$85.00$68.2124.62%50.02%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Apr 14, 2026RBC CapitalSector PerformSector Performhold
Feb 27, 2026Evercore ISIOutperformOutperformhold
Feb 13, 2026Wolfe ResearchOutperformPeer Performdowngrade
Jan 27, 2026RBC CapitalOutperformSector Performdowngrade
Jan 22, 2026Evercore ISIOutperformOutperformhold
Jan 22, 2026OppenheimerOutperformPerformdowngrade
Dec 23, 2025UBSNeutralNeutralhold
Dec 19, 2025OppenheimerOutperformOutperformhold
Dec 17, 2025RBC CapitalOutperformOutperformhold
Dec 08, 2025OppenheimerPerformOutperformupgrade

Financial Forecast

EPS Forecast

$-3 $-2 $-1 $0 $1 $2 $3 $4 $5 $6 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-1.54$-1.60$-0.72$1.80$4.95---
Avg Forecast$-1.89$-2.29$-1.29$1.34$1.97$3.21$4.15$5.66
High Forecast$-1.82$-2.26$-1.08$1.43$2.51$3.79$4.25$5.69
Low Forecast$-1.93$-2.32$-1.62$1.28$1.68$2.86$3.98$5.62
Surprise %-18.52%-30.13%-44.19%34.33%151.27%---

Revenue Forecast

$0 $400M $800M $1B $2B $2B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$233.39M$407.86M$624.80M$802.80M$911.98M---
Avg Forecast$229.61M$401.02M$619.50M$799.62M$949.63M$1.12B$1.31B$1.53B
High Forecast$232.81M$405.36M$619.55M$802.83M$952.32M$1.12B$1.31B$1.53B
Low Forecast$222.91M$396.31M$619.48M$795.90M$945.71M$1.12B$1.31B$1.52B
Surprise %1.65%1.70%0.86%0.40%-3.96%---

Net Income Forecast

$-100M $-40M $20M $80M $140M $200M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-42.04M$-44.88M$-21.15M$53.51M$145.42M---
Avg Forecast$-51.71M$-59.56M$-21.15M$39.71M$59.68M$92.64M$116.87M$165.97M
High Forecast$-41.37M$-47.65M$-16.92M$42.03M$73.68M$111.15M$124.43M$166.77M
Low Forecast$-62.05M$-71.47M$-25.38M$37.39M$49.22M$83.92M$116.59M$164.54M
Surprise %-18.69%-24.64%-34.76%143.68%---

INSP Forecast FAQ

Is Inspire Medical Systems stock a buy?

Inspire Medical Systems stock has a consensus rating of Hold, based on 27 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 13 Buy, 14 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Inspire Medical Systems is a neutral investment for most analysts.

What is Inspire Medical Systems's price target?

Inspire Medical Systems's price target, set by 27 Wall Street analysts, averages $91.33 over the next 12 months. The price target range spans from $56 at the low end to $180 at the high end, suggesting a potential 61.19% change from the previous closing price of $56.66.

How does Inspire Medical Systems stock forecast compare to its benchmarks?

Inspire Medical Systems's stock forecast shows a 61.19% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the medical device stocks industry (33.37%).

What is the breakdown of analyst ratings for Inspire Medical Systems over the past three months?

  • April 2026: 6.67% Strong Buy, 26.67% Buy, 66.67% Hold, 0% Sell, 0% Strong Sell.
  • March 2026: 5.88% Strong Buy, 23.53% Buy, 70.59% Hold, 0% Sell, 0% Strong Sell.
  • February 2026: 6.25% Strong Buy, 37.50% Buy, 56.25% Hold, 0% Sell, 0% Strong Sell.

What is Inspire Medical Systems’s EPS forecast?

Inspire Medical Systems's average annual EPS forecast for its fiscal year ending in December 2026 is $3.21, marking a -35.15% decrease from the reported $4.95 in 2025. Estimates for the following years are $4.15 in 2027, and $5.66 in 2028.

What is Inspire Medical Systems’s revenue forecast?

Inspire Medical Systems's average annual revenue forecast for its fiscal year ending in December 2026 is $1.12B, reflecting a 22.80% increase from the reported $911.98M in 2025. The forecast for 2027 is $1.31B, and $1.53B for 2028.

What is Inspire Medical Systems’s net income forecast?

Inspire Medical Systems's net income forecast for the fiscal year ending in December 2026 stands at $92.64M, representing a -36.29% decrease from the reported $145.42M in 2025. Projections indicate $116.87M in 2027, and $165.97M in 2028.